TUBERCULOSISAND HIV CO-INFECTION – A HORRIBLE SITUATION IN INDIA

Tuberculosis (TB) is an infection that most commonly attacks the lungs. As per the latest update around 8 crore people in India are suffering from Tuberculosis and among those around…

  • News
  • March 31, 2016
  • 70 views
Pune emerging as favourite hub for health tech startups in India

Pune is already known for a good source of talent from IT companies, manufacturing sector and educational institutes and of late the city has also developed enterprise culture. “Interestingly, Pune…

  • News
  • March 30, 2016
  • 69 views
Banned drug Ephedrine worth Rs 2,000 cr seized from chemical firm

Mumbai 17 A In one of the biggest drug hauls in Maharashtra, the Thane Police seized 18.5 tonnes of banned drug Ephedrine, valued at Rs 2,000 crore, from the Solapur…

  • News
  • March 30, 2016
  • 82 views
US IS IMPORTING BAN FDC EVEN TODAY

New Delhi: Top 20 companies in United State of America are the member of billion dollar FDC club and name of those members are Novartis, Merck, GSK, Astra Zeneca, Sanofi,…

Govt. descended Price of 126 drugs by 40%

New Delhi Government has fixed the ceiling price of 530 essential medicines that has resulted in price reduction of over 40 per cent in case of 126 drugs, Parliament. “National…

4,700 drugs illegally over-priced: NPPA

New Delhi The national drug price regulator NPPA has warned of action against companies violating its pricing norms as it found prices of more than 4,700 medicines had increased beyond…

DOP proposed to bring medical devices under Drug Price Control Order

New Delhi To control the high prices of medical devices such as stents and implants, Department of Pharmaceuticals has proposed to Health Ministry to bring them under the Drug Price…

Irrational FDCs will soon be ruled out from market

Mumbai As a part of government’s intent to efficiently supply medicines for patient safety at large, irrational fixed dose combinations (FDCs) will soon be ruled out from the healthcare system.…

Beyond the line of sight, there is change

Healthcare Insurance spokespersons in India made interesting statements of intent a couple of weeks ago. Insurance now intends to cover the costs of consultation and drugs even when no hospitalization…

PARADIGM SHIFT IN PHARMA REGULATORY VIGILANCE

New Delhi We agree that medicine is a double edged sword either saves life or kills life. Strong regulatory norms and regulatory vigilance can save more valuable life. Building strong…